<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02612207</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-24465</org_study_id>
    <nct_id>NCT02612207</nct_id>
  </id_info>
  <brief_title>Point-of-Care System for Determination of Bilirubin Capacity in Neonates</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Albert Einstein Healthcare Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aviv Biomedical, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this project are to validate the performance of the miniaturized and modernized
      hematofluorometer that measures bilirubin capacity into a product and is suitable for
      operation in various point of care environments when encountering confounding direct
      bilirubin, to complete the development of easy to use sample handling disposables, and to
      verify the performance of the system for samples from a specified population of neonates.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bilirubin Binding Capacity (BBC) on healthy and at-risk infants for impaired binding capacity by hematofluorometery assay</measure>
    <time_frame>&lt;14 days of life</time_frame>
    <description>To define normative data (mean, median, range, inter-quartile ranges) among these deemed healthy infants (including those who are at- risk) for increased vulnerability to impaired binding soon after birth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Natural history of BBC and stratification of those at risk of disordered bilirubin binding</measure>
    <time_frame>&lt;14 days of life</time_frame>
    <description>o delineate the prospective natural history of BBC and stratify those at most or least likely at risk of impaired bilirubin binding</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Jaundice, Neonatal</condition>
  <condition>Hyperbilirubinemia</condition>
  <condition>Bilirubin-Induced Neurological Dysfunction (BIND)</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bilirubin Binding Capacity by hematofluorometry</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of preterm (≥ 28 wks GA, BW≥1000g) as well as sick or
        unstable late-term newborns (infants ≥ 35 wks GA, BW≥2500g).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must meet all of the following inclusion criteria to be considered eligible
             for study enrollment soon after birth or re-admission (for phototherapy):

               -  Parental informed consent

               -  Male and female newborns with a GA ≥ 28 wks with a birthweight ≥ 1000 g including
                  infants with GA ≥ 35 wks with a birthweight ≥ 2500 g who are clinically deemed at
                  risk.

               -  Enrollment at age less than 14 days and more than 6h

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Lucile-Packard Children's Hospital at Stanford</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vinod K Bhutani, MD</last_name>
      <phone>650-723-5711</phone>
      <email>bhutani@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Martin E Castillo Cuadrado, BS</last_name>
      <phone>415-531-8778</phone>
      <email>martinc@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Vinod K Bhutani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Zupancic, MD</last_name>
      <email>jzupanci@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>John Zupancic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albert Enstein Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Magee-Womens' Hospital of University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jon F Watchko, MD</last_name>
      <phone>412-641-1834</phone>
      <email>watcjf@mail.magee.edu</email>
    </contact>
    <investigator>
      <last_name>Jon F Watchko, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical School at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Lamola AA, Bhutani VK, Du L, Castillo Cuadrado M, Chen L, Shen Z, Wong RJ, Stevenson DK. Neonatal bilirubin binding capacity discerns risk of neurological dysfunction. Pediatr Res. 2015 Feb;77(2):334-9. doi: 10.1038/pr.2014.191. Epub 2014 Nov 24.</citation>
    <PMID>25420178</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2015</study_first_submitted>
  <study_first_submitted_qc>November 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2015</study_first_posted>
  <last_update_submitted>April 13, 2017</last_update_submitted>
  <last_update_submitted_qc>April 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Vinod K. Bhutani</investigator_full_name>
    <investigator_title>Neonatologist, Professor of Pediatrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Hyperbilirubinemia</mesh_term>
    <mesh_term>Jaundice, Neonatal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bilirubin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

